+91 89257 70075 agathishaacademy@gmail.com

Home/Resources/Public Advisory

Public Advisory on Stem Cell &
Regenerative Therapies

As global interest in stem cell therapy grows, AISRM provides this advisory to inform patients, consumers and medical professionals about the current landscape of regenerative treatments, the risks of unverified clinics, and how to make informed healthcare decisions.

  • Patient Protection
  • Evidence-Based
  • Ethical Practice
  • Regulatory Awareness

Understanding Regenerative Therapies

Great promise — applied within
strict scientific frameworks

Regenerative medicine — including the use of stem cells, Platelet-Rich Plasma (PRP), Bone Marrow Aspirate Concentrate (BMAC) and Stromal Vascular Fraction (SVF) — holds significant promise for treating a variety of medical conditions.

However, it is crucial to understand that not all therapies marketed as "stem cell treatments" are scientifically validated, safe, or approved by regulatory bodies.

Our fellowship programs emphasise patient protection and evidence-based decision-making. We train our specialists to understand that regenerative therapies must be applied within strict ethical and scientific frameworks.

We advocate for treatments that are scientifically sound and prioritise patient safety above all else.
Patient First Evidence-based regenerative medicine

Warnings Regarding Unregulated Clinics

Exercise extreme caution with facilities that do the following

Worldwide, clinics have emerged offering unproven stem cell therapies, often touting unrealistic "100% success rates" or "cures" for complex conditions.

  • 01

    Offer "Cure-Alls"

    Beware of clinics claiming that a single stem cell treatment can cure a wide, unrelated range of diseases — for example, claiming to treat both orthopaedic joint pain and neurological disorders with the same injection.

  • 02

    Lack Medical Credentials

    Ensure that the facility is staffed by qualified physicians who have specialised training relevant to the condition being treated.

  • 03

    Use Unapproved Products

    Avoid clinics using unapproved, imported cellular products or products not processed in compliance with Good Manufacturing Practices (GMP). Unverified products can lead to severe adverse events, including life-threatening infections, immune rejection or unwanted tissue growths.

  • 04

    Bypass Clinical Trials

    Legitimate, experimental stem cell therapies should be conducted under the strict oversight of an Institutional Review Board (IRB) and registered as formal clinical trials.

One of the most significant risks of unverified stem cell treatments is that patients may delay or forgo proven, evidence-based medical treatments under the false hope of a quick cure. Delaying proper medical care can lead to the worsening of the underlying condition.

The Risks of Delaying Standard CareAISRM Public Advisory

Questions to Ask Before Treatment

Five questions that protect you

If you are considering a regenerative or stem cell therapy, we urge you to ask your physician these questions to ensure you receive safe, evidence-based care.

Ask whether the therapy is approved by national regulatory bodies (e.g., FDA, ICMR) for your specific condition, or whether it is part of an official, registered clinical trial. If neither, treat the offer with caution.
You are entitled to know whether the material comes from your own tissue (autologous) or donor tissue, and how it was processed. Compliant facilities can document this clearly.
Every legitimate procedure has documented risks. A provider unwilling or unable to discuss specific adverse reactions associated with the procedure is a warning sign.
Ask for published, peer-reviewed scientific studies supporting the effectiveness of this specific treatment for your specific condition — not general claims about stem cells.
A trustworthy physician will always explain the proven, standard treatment options alongside any regenerative therapy, so you can weigh them fairly before deciding.

Our Commitment to Medico-Legal Clarity

We are dedicated to ensuring our fellows navigate the ethical complexities of this field responsibly — and to helping the public make safe, informed decisions.

Ask Us a Question